Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis

Journal of Investigative Dermatology

Volumn 125, Issue 1, 2005, Pages 68-71

  Rubins, Andris ^a   Gutmane, Rita ^a   Valdmane, Nora ^a   Stevenson, Paul ^b   Foster, Claire ^b   Undre, Nasrullah ^b  

^a Latvijas Dermatologijas Instituta   (Latvia)

^b Fujisawa GmbH   (Germany)

Author keywords

Adults; Atopic dermatitis; Pharmacokinetics; Tacrolimus ointment

Indexed keywords

TACROLIMUS;

ADULT; AREA UNDER THE CURVE; ARTICLE; ATOPIC DERMATITIS; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; DERMATITIS; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; FEMALE; HUMAN; MALE; OINTMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN IRRITATION; TREATMENT OUTCOME;

EID: 22044435818     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2005.23754.x     Document Type: Article

References (13)

1. Boguniewicz M, Fiedler VC, Raimer S, et al: A randomized vehicle-controlled trial of tacrolimus ointment for the treatment of atopic dermatitis in children. J Allergy Clin Immunol 102:637-644, 1998
2. Cheer SM, Plosker GL: Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis. Am J Clin Dermatol 2:389-406, 2001
3. Furue M, Terao H, Rikishisa K, et al: Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol 148:128-133, 2003
4. Hanifin JM, Ling MR, Langley R, Breneman B, Rafal E and the Tacrolimus Ointment Study Group: Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy. J Am Acad Dermatol 44:28-38, 2001
5. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 92:44-47, 1980
6. Hill HM, Clarke SD, Bentley L, et al: A high sensitivity analysis for tacrolimus (FK506) in human blood. Pharm Res 14 (Suppl):261-262, 1997
7. Kang S, Lucky AW, Pariser D, Lawrence I, Hanifin JM and the Tacrolimus Ointment Study Group: Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. J Am Acad Dermatol 44:58-64, 2001
8. Möller A, Iwasaki K, Kawamura A, et al: The disposition of 14C-labelled tacrolimus after intravenous and oral administration in healthy human subjects. Drug Metab Disposition 27:633-636, 1999
9. Paller A, Eichenfeld LF, Leung DYM, Stewart D, Appell W and the Tacrolimus Ointment Study Group: A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol 44:47-57, 2001
10. Rajka G, Langeland T: Grading of the severity of atopic dermatitis. Acta Derm Venereol (Stockh) 144:13-14, 1989
11. Ruzicka T, Bieber T, Schöpf E, et al: A short-term trial of tacrolimus ointment for atopic dermatitis. N Engl J Med 337:816-821, 1997
12. Soter NA, Fleischer AB, Webster GF, Monroe E, Lawrence I and the Tacrolimus Ointment Study Group: Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part II, safety. J Am Acad Dermatol 44:39-46, 2001
13. Undre NA, van Hoof J, Christiaans M, et al: Pharmacokinetics of FK506 and mycophenolic acid after the administration of a FK506-based regimen in combination with mycophenolate mofetil in kidney transplantation. Transplant Proc 30:1299-1302, 1998